[Activities of plasma proteinases and their acid-stable urinary inhibitors in patients with arterial hypertension].
The data obtained allow to consider urine acid-stable proteinase inhibitor (ASPI) activity as an early and informative index of renal parenchyma damage in patients with renal symptomatic arterial hypertensions without significant urine changes. Urine ASPI activities seems to be useful in differentiation of patients with chronic glomerulonephritis without significant urine changes and patients with hypertensions.
Parfenkova
G A
GA
Orloblina
O G
OG
Sitina
V K
VK
D000293:Adolescent; D000328:Adult; D002648:Child; D002918:Chymotrypsin / Q000097:blood*; D005260:Female; D006023:Glycoproteins / Q000652:urine*; D006801:Humans; D006977:Hypertension, Renal / Q000209:etiology / Q000378:metabolism*; D007674:Kidney Diseases / Q000150:complications; D008297:Male; D008875:Middle Aged; D010196:Pancreatic Elastase / Q000097:blood*; D014118:Toxins, Biological / Q000097:blood
D006023:Glycoproteins; D014118:Toxins, Biological; C026865:uremia middle molecule toxins; D002918:Chymotrypsin; D010196:Pancreatic Elastase; C028665:urinastatin
Aktivnost' proteinaz v plazme krovi i kislotostabil'nykh ingibitorov v moche bol'nykh arterial'nymi gipertoniiami.